Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
Paediatrics
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
Paediatrics

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia

Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285275. Online ahead of print.

ABSTRACT

Not available.

PMID:38634143 | DOI:10.3324/haematol.2024.285275